Figure 5From: Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary reportMetabolic and inflammatory factors vs. ⊿SBP and ⊿DBP. (A). ⊿HMW-ADN vs. ⊿SBP: r=−0.090, P=0.630; (B). ⊿PAI-1 vs. ⊿SBP: r=0.241, P=0.207; (C). ⊿HMW-ADN vs. ⊿DBP: r=−0.382, P=0.165; (D). ⊿PAI-1 vs. ⊿DBP: r=0.210, P=0.285.Back to article page